Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5451 | 1621 | 29.5 | 60% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
139 | 3 | THYROID//THYROID CANCER//GRAVES DISEASE | 64904 |
224 | 2 | GRAVES DISEASE//THYROID//CONGENITAL HYPOTHYROIDISM | 20534 |
5451 | 1 | GRAVES DISEASE//RADIOIODINE THERAPY//HYPERTHYROIDISM | 1621 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GRAVES DISEASE | authKW | 867970 | 18% | 15% | 298 |
2 | RADIOIODINE THERAPY | authKW | 702512 | 7% | 31% | 120 |
3 | HYPERTHYROIDISM | authKW | 323965 | 12% | 9% | 192 |
4 | ANTITHYROID DRUGS | authKW | 294238 | 3% | 31% | 50 |
5 | RADIOIODINE TREATMENT | authKW | 202942 | 2% | 43% | 25 |
6 | RADIOIODINE | authKW | 186785 | 4% | 15% | 68 |
7 | TOXIC ADENOMA | authKW | 141979 | 1% | 54% | 14 |
8 | NUKLEARMEDIZIN-NUCLEAR MEDICINE | journal | 119831 | 5% | 7% | 86 |
9 | RADIOIODINE TEST | authKW | 113014 | 0% | 100% | 6 |
10 | TOXIC MULTINODULAR GOITER | authKW | 99080 | 1% | 48% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 13953 | 36% | 0% | 583 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 5456 | 23% | 0% | 375 |
3 | Medicine, General & Internal | 3322 | 22% | 0% | 354 |
4 | Surgery | 258 | 9% | 0% | 145 |
5 | Pediatrics | 160 | 4% | 0% | 72 |
6 | Medicine, Research & Experimental | 29 | 3% | 0% | 46 |
7 | Primary Health Care | 26 | 0% | 0% | 8 |
8 | Otorhinolaryngology | 24 | 1% | 0% | 20 |
9 | Tropical Medicine | 5 | 0% | 0% | 8 |
10 | Literary Reviews | 1 | 0% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ENDOCRINOL F112 | 56507 | 0% | 100% | 3 |
2 | GESUNDHEITSOKON MED GESELL | 42379 | 0% | 75% | 3 |
3 | KAWAGOE CLIN | 42379 | 0% | 75% | 3 |
4 | NUCLEO BIOESTATIST | 37671 | 0% | 100% | 2 |
5 | OLD CHILDRENS OUT PATIENTS | 37671 | 0% | 100% | 2 |
6 | PEDIAT CHAIRMANS OFF | 37671 | 0% | 100% | 2 |
7 | UNIV ENDOCRINOL DIABET METAB | 37671 | 0% | 100% | 2 |
8 | YALE PEDIAT THYROID | 33481 | 0% | 44% | 4 |
9 | CANC SAO PAULO STATE ICESP | 28250 | 0% | 50% | 3 |
10 | DEUT E GESELL AFT NUCLEAR MED | 25113 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUKLEARMEDIZIN-NUCLEAR MEDICINE | 119831 | 5% | 7% | 86 |
2 | THYROID | 38698 | 5% | 2% | 87 |
3 | NUKLEARMEDIZIN | 35419 | 2% | 7% | 26 |
4 | NUKLEARMEDIZINER | 32552 | 1% | 11% | 16 |
5 | CLINICAL ENDOCRINOLOGY | 10884 | 4% | 1% | 66 |
6 | JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 7847 | 6% | 0% | 100 |
7 | JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION | 7686 | 3% | 1% | 45 |
8 | ANNALES D ENDOCRINOLOGIE | 7162 | 2% | 1% | 28 |
9 | EUROPEAN JOURNAL OF ENDOCRINOLOGY | 6675 | 3% | 1% | 43 |
10 | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 4697 | 1% | 1% | 24 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GRAVES DISEASE | 867970 | 18% | 15% | 298 | Search GRAVES+DISEASE | Search GRAVES+DISEASE |
2 | RADIOIODINE THERAPY | 702512 | 7% | 31% | 120 | Search RADIOIODINE+THERAPY | Search RADIOIODINE+THERAPY |
3 | HYPERTHYROIDISM | 323965 | 12% | 9% | 192 | Search HYPERTHYROIDISM | Search HYPERTHYROIDISM |
4 | ANTITHYROID DRUGS | 294238 | 3% | 31% | 50 | Search ANTITHYROID+DRUGS | Search ANTITHYROID+DRUGS |
5 | RADIOIODINE TREATMENT | 202942 | 2% | 43% | 25 | Search RADIOIODINE+TREATMENT | Search RADIOIODINE+TREATMENT |
6 | RADIOIODINE | 186785 | 4% | 15% | 68 | Search RADIOIODINE | Search RADIOIODINE |
7 | TOXIC ADENOMA | 141979 | 1% | 54% | 14 | Search TOXIC+ADENOMA | Search TOXIC+ADENOMA |
8 | RADIOIODINE TEST | 113014 | 0% | 100% | 6 | Search RADIOIODINE+TEST | Search RADIOIODINE+TEST |
9 | TOXIC MULTINODULAR GOITER | 99080 | 1% | 48% | 11 | Search TOXIC+MULTINODULAR+GOITER | Search TOXIC+MULTINODULAR+GOITER |
10 | SUBTOTAL THYROIDECTOMY | 97135 | 1% | 37% | 14 | Search SUBTOTAL+THYROIDECTOMY | Search SUBTOTAL+THYROIDECTOMY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BONNEMA, SJ , HEGEDUS, L , (2012) RADIOIODINE THERAPY IN BENIGN THYROID DISEASES: EFFECTS, SIDE EFFECTS, AND FACTORS AFFECTING THERAPEUTIC OUTCOME.ENDOCRINE REVIEWS. VOL. 33. ISSUE 6. P. 920 -980 | 245 | 44% | 30 |
2 | GENOVESE, BM , NOURELDINE, SI , GLEESON, EM , TUFANO, RP , KANDIL, E , (2013) WHAT IS THE BEST DEFINITIVE TREATMENT FOR GRAVES' DISEASE? A SYSTEMATIC REVIEW OF THE EXISTING LITERATURE.ANNALS OF SURGICAL ONCOLOGY. VOL. 20. ISSUE 2. P. 660 -667 | 63 | 91% | 16 |
3 | BONNEMA, SJ , FAST, S , HEGEDUS, L , (2014) THE ROLE OF RADIOIODINE THERAPY IN BENIGN NODULAR GOITRE.BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 28. ISSUE 4. P. 619 -631 | 68 | 76% | 5 |
4 | GRAF, H , (2015) THERAPY OF ENDOCRINE DISEASE RECOMBINANT HUMAN TSH AND RADIOACTIVE IODINE THERAPY IN THE MANAGEMENT OF BENIGN MULTINODULAR GOITER.EUROPEAN JOURNAL OF ENDOCRINOLOGY. VOL. 172. ISSUE 2. P. - | 45 | 94% | 1 |
5 | STOKKEL, MPM , LUSTER, M , DIETLEIN, M , LASSMANN, M , JUNAK, DH , (2010) EANM PROCEDURE GUIDELINES FOR THERAPY OF BENIGN THYROID DISEASE.EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. VOL. 37. ISSUE 11. P. 2218-2228 | 52 | 79% | 27 |
6 | COOPER, DS , (2003) ANTITHYROID DRUGS IN THE MANAGEMENT OF PATIENTS WITH GRAVES' DISEASE: AN EVIDENCE-BASED APPROACH TO THERAPEUTIC CONTROVERSIES.JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. VOL. 88. ISSUE 8. P. 3474 -3481 | 54 | 89% | 45 |
7 | BONNEMA, SJ , FAST, S , HEGEDUS, L , (2011) NON-SURGICAL APPROACH TO THE BENIGN NODULAR GOITER: NEW OPPORTUNITIES BY RECOMBINANT HUMAN TSH-STIMULATED I-131-THERAPY.ENDOCRINE. VOL. 40. ISSUE 3. P. 344 -353 | 57 | 69% | 9 |
8 | RIVKEES, SA , (2016) CONTROVERSIES IN THE MANAGEMENT OF GRAVES' DISEASE IN CHILDREN.JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. VOL. 39. ISSUE 11. P. 1247 -1257 | 48 | 68% | 1 |
9 | ROSS, DS , BURCH, HB , COOPER, DS , GREENLEE, MC , LAURBERG, P , MAIA, AL , RIVKEES, SA , SAMUELS, M , SOSA, JA , STAN, MN , ET AL (2016) 2016 AMERICAN THYROID ASSOCIATION GUIDELINES FOR DIAGNOSIS AND MANAGEMENT OF HYPERTHYROIDISM AND OTHER CAUSES OF THYROTOXICOSIS.THYROID. VOL. 26. ISSUE 10. P. 1343 -1421 | 120 | 21% | 5 |
10 | ABRAHAM, P , AVENELL, A , MCGEOCH, SC , CLARK, LF , BEVAN, JS , (2010) ANTITHYROID DRUG REGIMEN FOR TREATING GRAVES' HYPERTHYROIDISM.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - | 44 | 83% | 22 |
Classes with closest relation at Level 1 |